Blood‐based biomarkers for the prediction of hypertrophic cardiomyopathy prognosis: a systematic review and meta‐analysis

Blood‐based biomarkers for the prediction of hypertrophic cardiomyopathy prognosis: a systematic review and meta‐analysis

Abstract Aims Hypertrophic cardiomyopathy (HCM) is the most prevalent monogenic heart disease. HCM is an important cause of sudden cardiac death and may also lead to outflow tract obstruction and heart failure. Disease severity is highly variable and risk stratification remains limited. Therefore, w...

Full description

Bibliographic Details
Main Authors: Mark Jansen, Sila Algül, Laurens P. Bosman, Michelle Michels, Jolanda van derVelden, Rudolf A. deBoer, J. Peter vanTintelen, Folkert W. Asselbergs, Annette F. Baas
Format: Article
Language:English
Published: Wiley 2022-10-01
Series:ESC Heart Failure
Subjects:
Hypertrophic cardiomyopathy
Prognosis
Heart failure
Sudden cardiac death
Biomarker
Systematic review
Online Access:https://doi.org/10.1002/ehf2.14073

Internet

https://doi.org/10.1002/ehf2.14073

Similar Items